HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica Hedvat Selected Research

nirmatrelvir and ritonavir drug combination

11/2022COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
1/2022Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica Hedvat Research Topics

Disease

3COVID-19
11/2022 - 01/2021
1Caliciviridae Infections
01/2022
1Hemorrhage
12/2021
1Thrombosis (Thrombus)
12/2021
1Liver Failure
01/2021
1Neoplasms (Cancer)
11/2018
1Venous Thromboembolism
11/2018

Drug/Important Bio-Agent (IBA)

2nirmatrelvir and ritonavir drug combinationIBA
11/2022 - 01/2022
2AnticoagulantsIBA
12/2021 - 11/2018
2apixabanIBA
12/2021 - 11/2018
1N-(2-cyanoethylene)urea (BA 1)IBA
11/2022
1sotrovimabIBA
11/2022
1nitazoxanide (NTZ)FDA Link
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2021
1DabigatranFDA Link
11/2018
1RivaroxabanIBA
11/2018

Therapy/Procedure

2Therapeutics
11/2022 - 12/2021
1Organ Transplantation
01/2021